Comparison of Tiotropium and Ipratropium in a Double-Blind, Double-dummy, Efficacy and Safety Study in Adults With COPD
Status:
Completed
Trial end date:
2003-03-01
Target enrollment:
Participant gender:
Summary
Comparison of 18 mcg of Tiotropium Inhalation Capsules and ipratropiumMetered Dose Inhaler (2
puffs of 20 mcg, four times daily) in a Double-Blind, Double-dummy, Efficacy and Safety Study
in Adults with Chronic Obstructive Pulmonary Disease (COPD).
The objective of this study is to compare the bronchodilator efficacy and safety of
tiotropium inhalation capsules (18 mcg once daily) and ipratropium MDI (2 puffs of 20 mcg
q.i.d.) in patients with chronic obstructive pulmonary disease (COPD).